Justin Saeks and Bruce Carlson[email protected]InfectiousAntigen tests drive COVID-19 test market to $10.5BEven in the fall of 2020, there are capacity limitations, questions about testing accuracy, and challenges with sample collection. But creative solutions have been emerging at labs to help ease the load during a difficult time.November 9, 2020Page 1 of 1Top StoriesImmunoassaysLucy Letby murder case flags immunoassays as unreliable for medical evidenceAt least one pathologist has said it was wrong for scientists representing Liverpool Clinical Laboratories to insist insulin poisoning was the only explanation in a series of high-profile newborn deaths in the U.K., The Telegraph reported.Pathology and AIDigital pathology rollouts race for proof-of-concept at national levelBiomarker Discovery & ValidationCaris Life Sciences embarks on 10K-sample breast cancer biomarker analysis projectFederal LegislationASCLS seeks support for med lab personnel actSponsor ContentBody composition in patients treated with Ozempic